Biofilm Formation Mechanisms of Pseudomonas aeruginosa Predicted via Genome-Scale Kinetic Models of Bacterial Metabolism

Abstract

A hallmark of Pseudomonas aeruginosa is its ability to establish biofilm-based infections that are difficult to eradicate. Biofilms are less susceptible to host inflammatory and immune responses and have higher antibiotic tolerance than free-living planktonic cells. Developing treatments against biofilms requires an understanding of bacterial biofilm-specific physiological traits. Research efforts have started to elucidate the intricate mechanisms underlying biofilm development. However, many aspects of these mechanisms are still poorly understood. Here, we addressed questions regarding biofilm metabolism using a genome-scale kinetic model of the P. aeruginosa metabolic network and gene expression profiles. Specifically, we computed metabolite concentration differences between known mutants with altered biofilm formation and the wild-type strain to predict drug targets against P. aeruginosa biofilms. We also simulated the altered metabolism driven by gene expression changes between biofilm and stationary growth-phase planktonic cultures. Our analysis suggests that the synthesis of important biofilm-related molecules, such as the quorum-sensing molecule Pseudomonas quinolone signal and the exopolysaccharide Psl, is regulated not only through the expression of genes in their own synthesis pathway, but also through the biofilm-specific expression of genes in pathways competing for precursors to these molecules. Finally, we investigated why mutants defective in anthranilate degradation have an impaired ability to form biofilms. Alternative to a previous hypothesis that this biofilm reduction is caused by a decrease in energy production, we proposed that the dysregulation of the synthesis of secondary metabolites derived from anthranilate and chorismate is what impaired the biofilms of these mutants. Notably, these insights generated through our kinetic model-based approach are not accessible from previous constraint-based model analyses of P. aeruginosa biofilm metabolism. Our simulation results showed that plausible, non-intuitive explanations of difficult-to-interpret experimental observations could be generated by integrating genome-scale kinetic models with gene expression profiles.

Association between biofilm and multi/extensive drug resistance in diabetic foot infection

“…P. aeruginosa clearly plays an important role in the pathogenesis of chronically infected wounds. Some studies highlight the importance of the PAO‐1, Psl and Pel genes in P. aeruginosa , which are responsible for the synthesis of exopolysaccharide, the main component of the biofilm structure . P. aeruginosa is capable of anaerobic respiration using nitrate in the absence of oxygen.…”

Metabolomics Reveals the Renoprotective Effect of N-butanol Extract and Amygdalin Extract From Amygdalus Mongolica in Rats With Renal Fibrosis

“…Nicotinate and nicotinamide metabolism, histidine metabolism and purine metabolism were in uenced by both BUT and AMY. We found that AMY also regulates the disruption of pentose and glucuronate interconversions, nicotinate and bile secretion [27]. Thus, these pathways were probably the main metabolic pathways involved in the therapeutic effect of the active ingredients in BUT [28].…”

Antioxidant and Quorum Quenching Activity against Pseudomonas aeruginosa SU-18 of some Edible Fruit Juices

“…Pseudomonas aeruginosa exhibits its pathogenicity by the formation of a biofilm with the association of different communities on the host surface. Biofilm formation is an ubiquitous behavior of Pseudomonas aeruginosa where the free-floating planktonic cells gets attached to the biotic or abiotic substratum with the help of extracellular appendages via flagella, type IV pili and cup fimbriae for adhesion and multiplies into a microcolony within a slimy secretion called as Extracellular matrix (ECM) 1 . The chronicity of disease by P. aeruginosa is fully accomplished on biofilm formation which brings out characteristic phenotypic and genotypic traits in the microbial community such as resistance to environmental challenges, antibiotic infiltration, and against the host immune system 2 .…”